awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q50102737-3E1F45C8-E5E0-4B94-A740-8B8E2EB1EB6C
Q50102737-3E1F45C8-E5E0-4B94-A740-8B8E2EB1EB6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50102737-3E1F45C8-E5E0-4B94-A740-8B8E2EB1EB6C
A phase 2 study of rituximab, cyclophosphamide, bortezomib and dexamethasone (R-CyBorD) in relapsed low grade and mantle cell lymphoma.
P2860
Q50102737-3E1F45C8-E5E0-4B94-A740-8B8E2EB1EB6C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50102737-3E1F45C8-E5E0-4B94-A740-8B8E2EB1EB6C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bb62d23b656030d6dd5379bbfeb8925764cc5215
P2860
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.